Overview

This trial is active, not recruiting.

Condition critical illness
Treatments protocolized sedation, protocolized sedation, with daily interruption
Sponsor Mount Sinai Hospital, Canada
Collaborator Canadian Institutes of Health Research (CIHR)
Start date January 2008
End date August 2011
Trial size 410 participants
Trial identifier NCT00675363, 85487

Summary

The purpose of this study is to determine whether the use of both a nurse-driven sedation protocol and daily sedative interruption, compared with a sedation protocol alone, result in better outcomes for mechanically ventilated adults.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification safety/efficacy study
Intervention model parallel assignment
Masking open label
Primary purpose supportive care
Arm
(Active Comparator)
Nurse-directed protocols for administering sedation and/or analgesia by continuous infusion.
protocolized sedation
Nurse-directed protocol for administering sedation and/or analgesia.
(Active Comparator)
Nurse-directed protocols for administering sedation and/or analgesia, with daily interruption of sedation/analgesia
protocolized sedation, with daily interruption
Nurse-directed protocols for administering sedation and/or analgesia, with daily interruption of sedation/analgesia

Primary Outcomes

Measure
time to successful extubation
time frame: This will be the length of time that the patient remains on continuous infusions of sedation and/or analgesia in the ICU. At 60 days, all study interventions will terminate, but patients will be followed for outcomes.

Secondary Outcomes

Measure
ICU and hospital lengths of stay, ICU and hospital mortality, Adverse events (e.g., self -removal of endotracheal tube)
time frame: This will be the length of time that the patient remains on continuous infusions of sedation and/or analgesia in the ICU. At 60 days, all study interventions will terminate, but patients will be followed for outcomes.

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - 18 years of age or over - Mechanically ventilated, with anticipated need for MV ≥48 hrs - ICU team has decided to initiate continuous sedative/analgesic infusion(s) - informed consent from patient and/or SDM Exclusion Criteria - Admission after resuscitation from cardiac arrest - Traumatic brain injury - Currently receiving neuromuscular blocking agents - Allergy to midazolam and lorazepam - Lack of commitment to aggressive treatment - Previous enrolment in SLEAP, or current enrolment in related trial

Additional Information

Official title A Randomized Trial of Daily Sedative Interruption in Critically Ill, Mechanically Ventilated Patients Being Managed With a Sedation Protocol
Principal investigator Sangeeta Mehta, M.D.
Description All critically ill, mechanically ventilated patients in the Intensive Care Unit receive medications to relieve pain and anxiety. However, accumulation of these medications can be associated with serious complications, most notably longer time on the breathing machine and in the ICU. Two strategies have been shown to dramatically improve patient outcomes: nurse-directed protocols for giving sedation, and daily interruption of sedation. However, these strategies have not been widely adopted, because of physicians' concerns, and because it is unclear which strategy is better. Given that patient outcome is improved with either of these strategies, the fundamental question that arises is whether patients managed with a combination of two strategies which both reduce drug accumulation (protocolized sedation and daily interruption) have an even better outcome than patients managed with only one of them (protocolized sedation).We are conducting a multicenter randomized trial in which 400 critically ill, mechanically ventilated patients will have their sedation managed with protocolized sedation alone, or both strategies. Primary outcomes are duration of mechanical ventilation and ICU and hospital lengths of stay. Secondary outcomes are the incidence of delirium, the use of neurologic tests, nurse and respiratory therapist effort associated with the sedation management, the incidence of patient self-removal of lines and tubes, and patient recall of the ICU stay. The results of this large multi-center trial will help to inform best practice with regard to sedation management of critically ill patients in Canada and elsewhere.
Trial information was received from ClinicalTrials.gov and was last updated in September 2011.
Information provided to ClinicalTrials.gov by Mount Sinai Hospital, Canada.